Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Wang Y, Yang C, Song Y, Coleman JR, et al. Proc Natl Acad Sci U S A 2021;118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Yang C, Song Y, Coleman JR, et al. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Proc Natl Acad Sci U S A 2021;118.
PMID: 34193524